TrialAntimicrobial agents and chemotherapy2016

Model-Based Phase 3 Dose Selection for HIV-1 Attachment Inhibitor Prodrug BMS-663068 in HIV-1-Infected Patients: Population Pharmacokinetics/Pharmacodynamics of the Active Moiety, BMS-626529.

Ishani Landry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.